Stay updated on Nivolumab Combo Therapy in Virus Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page.

Latest updates to the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page
- Check3 days agoChange DetectedRevision tag at the bottom of the page updated from v3.6.0 to v3.6.2, indicating a backend/template update. The user-facing content and the study details remain unchanged.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedEnrollment is now indicated as closed, and the page adds new navigation/help sections such as How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference0.3%

- Check25 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a small underlying platform/template update.SummaryDifference0.0%

- Check46 days agoChange DetectedA new publication citation for a 2021 J Immunother Cancer article on CheckMate 358 has been added, and the Erratum entry for that article has been deleted.SummaryDifference0.1%

- Check60 days agoChange DetectedA new Revision: v3.5.3 is displayed, replacing the previous Revision: v3.5.2, indicating a minor version update in the page metadata.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded a new publication entry for Ferris et al. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial, with an erratum, and updated the record revision to v3.5.2. Removed the older Ferris et al. J Immunother Cancer, 2021 citation and revision 3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo Therapy in Virus Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page.